Answers are grounded in this paper and cite their sources.
A ratiometric fluorescent nanoprobe was developed for Cathepsin B (CB)-associated sensing by integrating the aggregation-induced emission (AIE) property of copper nanoclusters (CuNCs) with a GFLG peptide-gated host−guest recognition strategy. The sensing system was constructed as a two-component assembly-based nanoplatform comprising FITC-doped silica nanospheres functionalized with azobenzene and GFLG (FS-AZO-GFLG) and SH-β-CD-capped CuNCs as initially separate nanoscale components. Upon CB-triggered cleavage of the GFLG sequence, the exposed azobenzene moieties promoted the assembly of CuNCs onto the silica platform through host−guest interactions, leading to enhanced red fluorescence, while the green fluorescence of the silica core remained relatively constant as an internal reference. Importantly, this enzyme-activated assembly not only generated a ratiometric optical signal but also promoted the association of CuNCs with the FS carrier, facilitating their co-internalization under the tested cellular conditions. The nanoprobe exhibited a concentration-dependent ratiometric response toward CB, with a detection limit of 3.6 μg mL−1. Selectivity and inhibition experiments supported a preferential response toward CB under the tested conditions. In cellular studies and in a subcutaneous tumor-bearing mouse model after local administration, higher red-to-green fluorescence ratios were observed under CB-rich conditions than in the corresponding controls. Cytotoxicity, histopathological examination, and serum biochemistry analyses suggested acceptable short-term biocompatibility under the experimental conditions. These results demonstrate a proof-of-concept supramolecular nanoplatform for Cathepsin B-associated ratiometric fluorescence sensing in biological models.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: